GENFLOW BIOSCIENCES PLC — Investor Relations & Filings
Filings indexed
142
across all filing types
Latest filing
2026-05-15
Annual Report
Country
GB
United Kingdom
Listing
IL
GENF
Genflow Biosciences PLC is a biotechnology company developing gene therapies that target the aging process. The company's primary mission is to slow or halt aging and reduce the incidence of age-related diseases in both humans and dogs, thereby extending healthspan. Its lead therapeutic candidate, GF-1002, is a gene therapy that delivers a centenarian variant of the Sirtuin 6 (SIRT6) gene. This specific gene variant has been identified in individuals who live to 100 years or more and has demonstrated promising results in pre-clinical studies.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Group of companies' accounts made up to 2025-12-31 | 2026-05-15 | English | |
| Annual financial statements 2025 | 2026-05-13 | English | |
| Annual financial statements 2025 | 2026-05-13 | English | |
| Exercise of Warrants and Issue of Equity | 2026-05-08 | English | |
| Annual Report 2025 | 2026-04-30 | English | |
| Final Results | 2026-04-30 | English |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46834865 | Group of companies' accounts made up to 2025-12-31 | 2026-05-15 | English | ||
| 45660039 | Annual financial statements 2025 | 2026-05-13 | English | ||
| 45660034 | Annual financial statements 2025 | 2026-05-13 | English | ||
| 44177338 | Exercise of Warrants and Issue of Equity | 2026-05-08 | English | ||
| 39133438 | Annual Report 2025 | 2026-04-30 | English | ||
| 39084660 | Final Results | 2026-04-30 | English | ||
| 37867403 | Expansion of Confidentiality Agreements | 2026-04-28 | English | ||
| 34688977 | Strategic Technology Collaboration | 2026-04-20 | English | ||
| 34392433 | International Patent Publication | 2026-04-13 | English | ||
| 33889131 | Update on the Dog Study | 2026-04-08 | English | ||
| 33101656 | Total Voting Rights | 2026-03-31 | English | ||
| 34566868 | Resolutions from GM | 2026-03-10 | English | ||
| 34566621 | Issue of Equity & PDMR Notifications | 2026-03-05 | English | ||
| 32863359 | Result of GM | 2026-03-02 | English | ||
| 32859832 | Receipt of First Tranche of Grant | 2026-03-02 | English | ||
Financials
Loading financials…
We couldn't load the financials
No data available yet
We have extracted financials for GENFLOW BIOSCIENCES PLC, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AIM ImmunoTech Inc.
Immuno-pharma company developing therapeutics for oncology,…
|
AIM | US | Professional, scientific and te… |
|
Ainos, Inc.
Develops AI-driven diagnostics, immune therapeutics, and te…
|
AIMD | US | Professional, scientific and te… |
|
Akela Pharma Inc.
Integrated drug developer focused on pain and inhalation, p…
|
— | CA | Professional, scientific and te… |
|
Akero Therapeutics, Inc.
Clinical-stage company developing treatments for serious me…
|
AKRO | US | Professional, scientific and te… |
|
Aladdin Healthcare Technologies SE
Develops AI-powered tools for drug discovery and diagnostic…
|
NMI | DE | Professional, scientific and te… |
|
Alamar Biosciences, Inc.
Powering precision proteomics for earliest disease detectio…
|
ALMR | US | Professional, scientific and te… |
|
Alaunos Therapeutics, Inc.
Clinical-stage immuno-oncology company developing TCR-T cel…
|
TCRT | US | Professional, scientific and te… |
|
ALGORAE PHARMACEUTICALS LIMITED
Biopharmaceutical firm using AI to develop neurodegenerativ…
|
1AI | AU | Professional, scientific and te… |
|
Aligos Therapeutics, Inc.
A clinical-stage biopharmaceutical company developing thera…
|
ALGS | US | Professional, scientific and te… |
|
Allelix Biopharmaceuticals Inc.
Biopharmaceutical R&D focused on protein-based drugs and ne…
|
ALX | CA | Professional, scientific and te… |
GENFLOW BIOSCIENCES PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/5094/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=5094 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=5094 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=5094 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 5094}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for GENFLOW BIOSCIENCES PLC (id: 5094)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.